Do sulfonamides still have a place in dermatologic therapy?;Haben sulfonamide noch ihren platz in der dermatotherapie?

Hautarzt

Volumn 53, Issue 3, 2002, Pages 163-166

  Schnuch, Axel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; MACROLIDE; MAFENIDE; SALAZOSULFAPYRIDINE; SULFACETAMIDE; SULFADIAZINE; SULFADIAZINE SILVER; SULFAMERAZINE; SULFANILAMIDE; SULFATHIAZOLE; SULFONAMIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CLINICAL PRACTICE; CONTACT DERMATITIS; CROHN DISEASE; DERMATOLOGY; DRUG CHOICE; DRUG STRUCTURE; DRUG USE; HUMAN; NOTE; RISK ASSESSMENT; SKIN ALLERGY; STREPTOCOCCUS INFECTION;

ADMINISTRATION, TOPICAL; ANTI-INFECTIVE AGENTS; DRUG ERUPTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; RISK FACTORS; SKIN DISEASES, BACTERIAL; SULFONAMIDES;

EID: 0036955789     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-001-0322-8     Document Type: Note

References (42)

1. Breneman DL, Ariano MC (1993) Successful treatment of acne vulgaris in women with a new topical sodium sulfacetamide/sulfur lotion. Int J Dermatol 32:365-367
2. Gloor M, Thoma K, Flur J (2000) Dermatologische Externatherapie. Unter besonderer Berücksichtigung der Magistralrezeptur. Springer, Berlin Heidelberg New York Tokyo, S 1-469
3. Höger PH (1998) Topische Antibiotika und Antiseptika. Agentien, Spektren, Nebenwirkungen. Hautarzt 49:331-347
4. Bundesgesundheitsamt-Kommission-B-6 (1991) Bekanntmachung über die Zulassung und Registrierung von Arzneimitteln. Aufbereitungsmonographien der Kommission B 6. Sulfacetamid, Sulfadicramid, Sulfisomidin. Pharm Ztg 136:2250-2251
5. Bundesgesundheitsamt-Kommission-B-6 (1990) Bekanntmachung über die Zulassung und Registrierung von Arzneimitteln. Aufbereitungsmonographien der Kommission B 6. Sulfadimidin, Sulfaguanidin, Sulfamerazin. Pharm Ztg 135:827-828
6. Fischer H, Reimann H (2000) Sulfonamide nicht auf die Haut. Pharm Ztg 145:2304
7. Simon C, Stille W (1993) Antibiotika-Therapie in Klinik und Praxis, 8. Aufl. Schattauer, Stuttgart
8. Korting HC, Abeck D, Grimm W, Schiller Y (1990) Heutige In-vitro-Empfindlichkeit von Hautbakterien gegenüber unterschiedlichen Chemotherapeutika. Quantitative Ergebnisse des Mikrodilutionstests. Akt Dermatol 16:27-31
9. Huovinen P, Sundström L, Swedberg G, Sköld O (1995) Trimethoprim and sulfonamide resistance. Antimicrob Ag Chemother 39:279-289
10. Mockenhaupt M, Schöpf E (1996) Epidemiology of drug-induced severe skin reactions. Semin Cutan Med Surg 15:236-243
11. Margolis DJ, Bondi EE (1990) Toxic epidermal necrolysis associated with sulfonamides. Int J Dermatol 29:153
12. N.N. (1971) Mafenide acetate cream: a review. Drugs 1:434-460
13. Breit R, Seifert P (1989) Mafenide - still an allergen of importance? In: Frosch PJ, Dooms-Goossens A, Lachapelle JM, Rycroft RJG, Scheper RJ (eds) Current topics in contact dermatitis. Springer, Berlin Heidelberg, New York Tokyo, pp 222-225
14. Enders F, Przybilla B, Ring J, Burg G, Braun-Falco O (1988) Epikutantestung mit einer Standardreihe - Ergebnisse bei 12.026 Patienten. Hautarzt 39:779-786
15. Enders F, Przybilla B, Ring J, Gollhausen R (1989) Patch test results in 1987 compared to trends from the period 1977-1983. Contact Dermat 20:230-232
16. Scheuer B, Rüther T, v. Bülow V et al. (1992) Häufige Kontaktallergene - Eine praxisorientierte Multicenterstudie. Akt Dermatol 18:44-49
17. Fernandez JC, Gamboa P, Jauregui I, Gonzalez G, Antepara I (1992) Concomitant sensitization to enoxolone and mafenide in a topical medicament. Contact Dermat 27:262
18. Sanz-de-Galdeano C, Aguirre A, Oleaga JM, Goday J, Diaz-Perez JL (1993) Allergic contact dermatitis from topical mafenide. Contact Dermat 28:249
19. Rudzki E, Rebandel P (1987) Primary sensitivity to sulphonamide and secondary sensitization to aromatic amines. Contact Dermat 17:49
20. Angelini G, Meneghini CL (1981) Oral tests in contact allergy to para-amino compounds. Contact Dermat 7:311-314
21. Uter W, Geier J, Fuchs T, Richter G (2001) Das Epikutantest-Screening mit "Parastoffen". Dermatol Beruf Umwelt 49:42
22. Valsecchi R, Foiadelli L, Cainelli T (1986) Is silver sulfadiazine a sensitizer? Contact Dermat 15:45
23. Kleniewska D, Maibach H (1980) Allergenicity of aminobenzene compounds: structure-function relationships. Derm Beruf Umwelt 28:11-13
24. Basketter DA, Scholes EW, Cumberbatch M, Evans CD, Kimber I (1992) Sulphanilic acid: divergent results in the guinea pig maximization test and the local lymph node assay. Contact Dermat 27:209-213
25. Lepoittevin JP, Basketter DA, Goossens A, Karlberg AT (1998) Allergic contact dermatitis. The molecular basis. Springer, Berlin Heidelberg New York Tokyo
26. Editorial (1978) Antibiotic resistance and topical treatment. Br Med J 1:649-650
27. Richet H, Andre-Richet B, Le Gallou FI (2001) Que penser des resistances bacteriennes dans l'acne? Ann Dermatol Venereol 128:2S15-2S17
28. Simpson N (2001) Antibiotics in acne: time for a rethink. Editorial. Br J Dermatol 144:225-227
29. Grumbach A, Hegglin R (1942) Klinischbakteriologische Untersuchungen über die Sulfonamid-Resistenz der Pneumokokken. Schweiz Med Wochenschr 72:1369-1376
30. Mandell GL, Sande MA (1980) Antimicrobial agents: sulfonamides, trimethoprim-sulfamethoxazole, and urinary tract antiseptics. In: Goodman Gilman A, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 6th edn. Macmillan Publishing, New York, pp 1106-1125
31. Brumfitt W, Hamilton-Miller JM (1995) Combinations of sulphonamides with diaminopyrimidines: how, when and why? J Chemother 7:136-139
32. Lane MR, Allan RN, Pease PE (1988) Antibiotic resistance in Escherichia coli from patients on sulphasalazine. Lancet 1 (No. 8599):1403-1404
33. Whitney CG, Farley MM, Hadler J et al. (2000) Increasing prevalence of multidrug-resistant streptococcus peumoniae in the United States. N Engl J Med 343:1917-1924
34. Krummel T, Dimitrov Y, Moulin B, Hannedouche T (2000) Drug points: acute renal failure induced by topical ketoprofen. Br Med J 320:93
35. Schmidt KU, Wagner G, Mensing H (1987) Ostrogen-induzierte Gynäkomastie nach Anwendung östrogenhaltiger Lokaltherapeutika. Dtsch Med Wochenschr 112:926-928
36. Miller YW, Eady EA, Lacey RW, Cove JH, Joanes DN, Cunliffe WJ (1996) Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. J Antimicrob Chemother 38:829-837
37. Enne V, Livermore DM, Stephens P, Hall LMC (2001) Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 357:1325-1328
38. Cunha BA (2001) Effective antibiotic-resistance control strategies. Commentary. Lancet 357:1307-1308
39. Ravenscroft JC, Layton A, Barnham M (2000) Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK. Clin Exp Dermatol 25:327-330
40. Wallmann J (1999) Antibakterielle Chemotherapie unter dem Aspekt der Antibiotikaresistenz. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschuz 42:58-61
41. McDonnell G, Denver Russell A (1999) Antiseptics and desinfectants: activity, action, and resistance. Clin Microbiol Rev 12:147-179
42. N.N. (2001) Keine Leistungspflicht der GKV für Altarzneimittel ohne Nachzulassung. Arzneitelegramm 32:103